"10.1371_journal.pone.0147129","plos one","2016-01-25T00:00:00Z","Eva C Schulte; Elisabeth Altmaier; Hannah S Berger; Kieu Trinh Do; Gabi Kastenmüller; Simone Wahl; Jerzy Adamski; Annette Peters; Jan Krumsiek; Karsten Suhre; Bernhard Haslinger; Andres Ceballos-Baumann; Christian Gieger; Juliane Winkelmann","Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, 81675, Munich, Germany; Institut für Humangenetik, Helmholtz Zentrum München, 85764, Neuherberg, Germany; Institute of Genetic Epidemiology, Helmholtz Zentrum München, 85764, Neuherberg, Germany; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, 85764, Neuherberg, Germany; Institute of Computational Biology, Helmholtz Zentrum München, 85764, Neuherberg, Germany; Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum München, 85764, Neuherberg, Germany; Institute of Epidemiology II, Helmholtz Zentrum München, 85764, Neuherberg, Germany; Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, 85764, Neuherberg, Germany; Lehrstuhl für Experimentelle Genetik, Technische Universität München, Freising-Weihenstephan, Germany; Department of Physiology and Biophysics, Weill Cornell Medical College in Qatar, Qatar Foundation–Education City, PO Box 24144, Doha, Qatar; Schön Klinik München Schwabing, Munich, Germany; Institut für Humangenetik, Technische Universität München, 81675, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Neurology and Neurosciences, Stanford University, Palo Alto, CA, 94304, United States of America","Conceived and designed the experiments: ECS HSB GK JA AP KS BH ACB CG JW. Performed the experiments: ECS HSB. Analyzed the data: EA KTD JK SW. Contributed reagents/materials/analysis tools: JA JW BH ACB. Wrote the paper: ECS EA JW CG.","Dr. Kastenmüller has a patent pending which is not related to the submitted analysis (Identity elucidation of unknown metabolites, EP 2726636 A2, PCT/US2012/043461). Dr. Winkelmann received personal fees from Xenoport and grant support from UCB outside the submitted work. Serum metabolic profiles of KORA controls were partly financed from Pfizer Worldwide Research and Development (http://www.pfizer.com/). This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","Eva C Schulte","ECS",14,TRUE,10,2,4,4,TRUE,FALSE,FALSE,0,NA,FALSE
